Jing Lin

机构：Guangdong Pharmaceutical University · ORCID：0000-0001-7707-8066

发表论文 114 篇 · 总被引 3934 次 · h-index 35

代表论文

• Near-infrared laser-controlled nitric oxide-releasing gold nanostar/hollow polydopamine Janus nanoparticles for synergistic elimination of methicillin-resistant Staphylococcus aureus and wound healing (2022 · Acta Biomaterialia · 被引 93)
• Novel 2-Substituted 3-Hydroxy-1,6-dimethylpyridin-4(1H)-ones as Dual-Acting Biofilm Inhibitors of Pseudomonas aeruginosa (2020 · Journal of Medicinal Chemistry · 被引 66)
• New Pqs Quorum Sensing System Inhibitor as an Antibacterial Synergist against Multidrug-Resistant Pseudomonas aeruginosa (2021 · Journal of Medicinal Chemistry · 被引 64)
• Design and Synthesis of 3-Hydroxy-pyridin-4(1 H )-ones–Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa (2023 · Journal of Medicinal Chemistry · 被引 40)
• Knowledge, attitudes and practices concerning catheter‐associated urinary tract infection amongst healthcare workers: a mixed methods systematic review (2022 · Nursing Open · 被引 39)
• (-)-Epigallocatechin-3-gallate (EGCG) modulates polarized macrophages to suppress M1 phenotype and promote M2 polarization in vitro and in vivo (2021 · Journal of Functional Foods · 被引 34)